Related Experiment Video
Updated: Dec 4, 2025
06:24
Author Spotlight: Liujunzi Decoction as a Traditional Chinese Treatment for Coloproctitis Cancer
Published on: October 13, 2023
1.4K
Colchicine: An Ancient Drug with Multiple Benefits
Georges El Hasbani1, Ali Jawad2, Imad Uthman1
1Division of Rheumatology, Department of Internal Medicine, American University of Beirut Medical Center, Beirut, Lebanon.
Current Pharmaceutical Design
|October 26, 2020
Summary
Colchicine, a long-used medication, effectively treats rheumatic and cardiac conditions like gout and pericarditis. It is also safe during pregnancy and lactation, though further research is needed for other potential uses.
Area of Science:
- Pharmacology
- Rheumatology
- Cardiology
Background:
- Colchicine has a long history of use, dating back to ancient Egypt.
- It has been a primary treatment for rheumatic and cardiac diseases.
- Its primary mechanism involves interaction with tubulin, affecting intracellular targets.
Purpose of the Study:
- To review the established and potential therapeutic applications of colchicine.
- To summarize the safety profile of colchicine, including during pregnancy and lactation.
- To identify areas where further research on colchicine is warranted.
Main Methods:
- Review of clinical trials and meta-analyses.
- Examination of historical usage and established indications.
- Assessment of emerging evidence for off-label uses.
Main Results:
- Colchicine is safely recommended for recurrent pericarditis, gout, familial Mediterranean fever, and Behçet's disease.
- It can be used as monotherapy or an add-on treatment.
- The drug has demonstrated safety during pregnancy and lactation.
Conclusions:
- Colchicine is a well-established and safe treatment for several inflammatory conditions.
- Its efficacy in preventing acute coronary syndrome, stroke, and treating pneumonia remains under investigation.
- Further research is necessary to fully elucidate colchicine's therapeutic potential and limitations.
More Related Videos
Related Concept Videos
01:10Drugs that Destabilize Microtubules
2.5K
Microtubules are dynamic structures and can be regulated by microtubule targeting agents (MTAs). Microtubule destabilizing drugs are a class of MTAs that destabilize and prevent microtubules' polymerization. Both natural and synthetic chemicals can be found under this class of drugs. Vincristine and vinblastine, two vinca alkaloids, and colchicine were among the first to be discovered. These drugs can affect cells in various ways, either by inducing a change in cell morphology, preventing...
2.5K
01:27Combined Effects of Drugs: Synergism
6.2K
Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...
Such synergistic combinations...
6.2K
01:15Drugs that Stabilize Microtubules
2.4K
Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
2.4K
01:11Direct-Acting Cholinergic Agonists: Therapeutic Uses
1.4K
Direct-acting cholinergic agonists have many therapeutic uses in various medical fields. Choline esters, including acetylcholine, have limited clinical utility due to their non-selectivity and short duration of action. Still, acetylcholine and carbachol are applied topically during ophthalmologic surgery to induce miosis. Pilocarpine, a muscarinic and ganglionic stimulator, effectively treats open-angle glaucoma and alleviates xerostomia and dry mouth caused by radiotherapy or Sjögren...
1.4K
01:20Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors
901
Antiplatelet drugs emerge as frontline defenders against the insidious threat of thromboembolic diseases, where abnormal clots obstruct vital blood vessels. These drugs stand as bulwarks, inhibiting platelet aggregation and clot formation, thereby mitigating the risk of life-threatening conditions like myocardial infarction, coronary artery disease, and thrombotic strokes.
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
901
01:30Indirect-Acting Cholinergic Agonists: Pharmacological Actions
1.2K
Indirect-acting cholinergic agonists, also known as anticholinesterases, exert their pharmacological effects by enhancing cholinergic transmission in various body parts, including the neuromuscular junction, autonomic cholinergic synapses, and the brain.
At the neuromuscular junction, these agents work by inhibiting the breakdown of acetylcholine, allowing it to remain bound to the receptor and bind to nearby receptors. This process leads to repetitive firing of the endplate, causing muscle...
At the neuromuscular junction, these agents work by inhibiting the breakdown of acetylcholine, allowing it to remain bound to the receptor and bind to nearby receptors. This process leads to repetitive firing of the endplate, causing muscle...
1.2K